263 related articles for article (PubMed ID: 15753911)
1. Use of beta-blockers during immunotherapy for Hymenoptera venom allergy.
Müller UR; Haeberli G
J Allergy Clin Immunol; 2005 Mar; 115(3):606-10. PubMed ID: 15753911
[TBL] [Abstract][Full Text] [Related]
2. Hymenoptera venom allergy.
Przybilla B; Ruëff F
J Dtsch Dermatol Ges; 2010 Feb; 8(2):114-27; quiz 128-30. PubMed ID: 19751222
[TBL] [Abstract][Full Text] [Related]
3. Systemic and local reactions of bee venom immunotherapy in Iran.
Bemanian MH; Farhoudi A; Pourpak Z; Gharagozlou M; Movahedi M; Nabavi M; Mozafari H; Mohammadzadeh I; Chavoshzadeh Z; Shirkhoda Z
Iran J Allergy Asthma Immunol; 2007 Dec; 6(4):203-6. PubMed ID: 18094443
[TBL] [Abstract][Full Text] [Related]
4. Analysis of safety, risk factors and pretreatment methods during rush hymenoptera venom immunotherapy.
Gorska L; Chelminska M; Kuziemski K; Skrzypski M; Niedoszytko M; Damps-Konstanska I; Szymanowska A; Siemińska A; Wajda B; Drozdowska A; Jutel M; Jassem E
Int Arch Allergy Immunol; 2008; 147(3):241-5. PubMed ID: 18594155
[TBL] [Abstract][Full Text] [Related]
5. Patients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased venom doses.
Ruëff F; Wenderoth A; Przybilla B
J Allergy Clin Immunol; 2001 Dec; 108(6):1027-32. PubMed ID: 11742283
[TBL] [Abstract][Full Text] [Related]
6. Specific immunotherapy in honeybee venom allergy: a comparative study using aqueous and aluminium hydroxide adsorbed preparations.
Ruëff F; Wolf H; Schnitker J; Ring J; Przybilla B
Allergy; 2004 Jun; 59(6):589-95. PubMed ID: 15147443
[TBL] [Abstract][Full Text] [Related]
7. Risk assessment of Hymenoptera re-sting frequency: implications for decision-making in venom immunotherapy.
von Moos S; Graf N; Johansen P; Müllner G; Kündig TM; Senti G
Int Arch Allergy Immunol; 2013; 160(1):86-92. PubMed ID: 22948338
[TBL] [Abstract][Full Text] [Related]
8. Rapid venom immunotherapy is safe for routine use in the treatment of patients with Hymenoptera anaphylaxis.
Bernstein JA; Kagen SL; Bernstein DI; Bernstein IL
Ann Allergy; 1994 Nov; 73(5):423-8. PubMed ID: 7978535
[TBL] [Abstract][Full Text] [Related]
9. Outcome survey of insect venom allergic patients with venom immunotherapy in a rural population.
Roesch A; Boerzsoenyi J; Babilas P; Landthaler M; Szeimies RM
J Dtsch Dermatol Ges; 2008 Apr; 6(4):292-7. PubMed ID: 18042250
[TBL] [Abstract][Full Text] [Related]
10. Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice.
Bonifazi F; Jutel M; Biló BM; Birnbaum J; Muller U;
Allergy; 2005 Dec; 60(12):1459-70. PubMed ID: 16266376
[TBL] [Abstract][Full Text] [Related]
11. [Immunotherapy against hymenoptera venom: report of ten patients].
Guzmán M MA; Salinas L J; Toche P P; Marinovic M MA; Gallardo O AM
Rev Med Chil; 2007 Dec; 135(12):1566-71. PubMed ID: 18357358
[TBL] [Abstract][Full Text] [Related]
12. Influence of total IgE levels on the severity of sting reactions in Hymenoptera venom allergy.
Sturm GJ; Heinemann A; Schuster C; Wiednig M; Groselj-Strele A; Sturm EM; Aberer W
Allergy; 2007 Aug; 62(8):884-9. PubMed ID: 17620065
[TBL] [Abstract][Full Text] [Related]
13. Insect sting anaphylaxis and beta-adrenergic blockade: a relative contraindication.
Awai LE; Mekori YA
Ann Allergy; 1984 Jul; 53(1):48-9. PubMed ID: 6146275
[TBL] [Abstract][Full Text] [Related]
14. Immunoblot studies in allergic patients to hymenoptera venom before and during immunotherapy.
Pereira Santos MC; Pedro E; Spínola Santos A; Branco Ferreira M; Palma Carlos ML; Palma Carlos AG
Eur Ann Allergy Clin Immunol; 2005 Sep; 37(7):273-8. PubMed ID: 16285233
[TBL] [Abstract][Full Text] [Related]
15. Maintenance venom immunotherapy administered at 3-month intervals is both safe and efficacious.
Goldberg A; Confino-Cohen R
J Allergy Clin Immunol; 2001 May; 107(5):902-6. PubMed ID: 11344360
[TBL] [Abstract][Full Text] [Related]
16. [Clinical and biological surveillance after the cessation of Hymenoptera venom desensitization].
Touraine F; Talayrach D; Florea O; Brianchon Ch; Preux PM; Bonnaud F
Eur Ann Allergy Clin Immunol; 2003 Nov; 35(9):335-9. PubMed ID: 14716961
[TBL] [Abstract][Full Text] [Related]
17. [Effect of rush immunotherapy (RIT) on Hymenoptera allergy].
Hirata H; Yukawa T; Arima M; Yamada G; Makino S; Fukuda T
Arerugi; 1999 Dec; 48(12):1331-6. PubMed ID: 10666921
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of Hymenoptera venom allergy.
Biló BM; Rueff F; Mosbech H; Bonifazi F; Oude-Elberink JN;
Allergy; 2005 Nov; 60(11):1339-49. PubMed ID: 16197464
[TBL] [Abstract][Full Text] [Related]
19. Mastocytosis and Hymenoptera venom allergy.
Ruëff F; Placzek M; Przybilla B
Curr Opin Allergy Clin Immunol; 2006 Aug; 6(4):284-8. PubMed ID: 16825870
[TBL] [Abstract][Full Text] [Related]
20. Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis.
González de Olano D; Alvarez-Twose I; Esteban-López MI; Sánchez-Muñoz L; de Durana MD; Vega A; García-Montero A; González-Mancebo E; Belver T; Herrero-Gil MD; Fernández-Rivas M; Orfao A; de la Hoz B; Castells MC; Escribano L
J Allergy Clin Immunol; 2008 Feb; 121(2):519-26. PubMed ID: 18177694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
